Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.

Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.

Shin W, Hompesch M, Byeon J, Kang S, Choi J, Baek S. Diabetes Obes Metab. 2023 Jun 13. doi: 10.1111/dom.15162.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?